Literature DB >> 30998640

What Is the Association Between Hospital Volume and Complications After Revision Total Joint Arthroplasty: A Large-database Study.

Benjamin F Ricciardi1, Andrew Y Liu, Bowen Qiu, Thomas G Myers, Caroline P Thirukumaran.   

Abstract

BACKGROUND: Studies of primary total joint arthroplasty (TJA) show a correlation between hospital volume and outcomes; however, the relationship of volume to outcomes in revision TJA is not well studied. QUESTIONS/PURPOSES: We therefore asked: (1) Are 90-day readmissions more likely at low-volume hospitals relative to high-volume hospitals after revision THA and TKA? (2) Are in-hospital and 90-day complications more likely at low-volume hospitals relative to high-volume hospitals after revision THA and TKA? (3) Are 30-day mortality rates higher at low-volume hospitals relative to high-volume hospitals after revision THA and TKA?
METHODS: Using 29,948 inpatient stays undergoing revision TJA from 2008 to 2014 in the Statewide Planning and Research Cooperative System (SPARCS) database for New York State, we examined the relationship of hospital revision volume by quartile and outcomes. The top 5 percentile of hospitals was included as a separate cohort. Advantages of the SPARCS database include comprehensive catchment of all cases regardless of payer, and the ability to track each patient across hospital admissions at different institutions within the state. The outcomes of interest included 90-day all-cause readmission rates and 30- and 90-day reoperation rates, postoperative complication rates, and 30-day mortality rates. The initial cohort that met the MS-DRG and ICD-9 criteria consisted of 30,354 inpatient stays for revision hip or knee replacements. Exclusions included patients with a missing patient identifier (n = 221), missing admission or discharge dates (n = 5), and stays from hospitals that were closed during the study period (n = 180). Our final analytic cohort comprised 29,948 inpatient stays for revision hip and knee replacements from 25,977 patients who had nonmissing data points for the variables of interest. Outcomes were adjusted for underlying hospital, surgeon, and patient confounding variables. The analytic cohort included observations from 25,977 patients, 138 hospitals, 929 surgeons, 14,130 revision THAs, 11,847 revision TKAs, 15,341 female patients (59% of cohort).
RESULTS: Patients had lower all-cause 90-day readmission rates in the highest 5th percentile by volume hospitals relative to all other lower hospital volume categories. Reoperation rates within the first 90 days, however, were not different among volume categories. All-cause 90-day readmissions were higher in the quartile 4 hospitals excluding the top 5th percentile (17%) versus the top 5th percentile by volume hospitals (12%) (odds ratio [OR]: 1.3; 95% confidence interval [CI], 1.0-1.5; p = 0.030). All-cause 90-day readmissions were higher in the quartile 3 hospitals (18%) relative to the top 5 percentile by volume hospitals (12%) (OR: 1.5; 95% CI, 1.2-1.9; p < 0.001). All-cause 90-day readmissions were higher in quartile 2 hospitals (18%) relative to the top 5 percentile by volume hospitals (12%) (OR: 1.4; 95% CI, 1.1-1.8; p = 0.010). All-cause 90-day readmissions were higher in quartile 1 hospitals (21%) versus the top 5 percentile by volume hospitals (12%) (OR: 1.6; 95% CI, 1.1-2.3; p = 0.010). Postoperative complication rates were higher among only the quartile 1 hospitals compared with institutions in each higher-volume category after revision TJA. The odds of 90-day complications compared with quartile 1 hospitals were 0.49 (95% CI, 0.33-0.72; p = 0.010) for quartile 2, 0.60 (95% CI, 0.40-0.88; p = 0.010) for quartile 3, 0.43 (95% CI, 0.28-0.64; p = 0.010) for quartile 4 excluding top 5 percentile, and 0.36 (95% CI, 0.22-0.59; p = 0.010) for the top 5 percentile of hospitals. There does not appear to be an association between 30-day mortality rates and hospital volume in revision TJA. The odds of 30-day mortality compared with quartile 1 hospitals were 0.54 (95% CI, 0.20-1.46; p = 0.220) for quartile 2, 0.75 (95% CI, 0.30-1.91; p = 0.550) for quartile 3, 0.57 (95% CI, 0.22-1.49; p = 0.250) for quartile 4 excluding top 5 percentile, and 0.61 (95% CI, 0.20-1.81; p = 0.370) for the top 5 percentile of hospitals.
CONCLUSIONS: These findings suggest that regionalizing revision TJA services, or concentrating surgical procedures in higher-volume hospitals, may reduce early complications rates and 90-day readmission rates. Disadvantages of regionalization include reduced access to care, increased patient travel distances, and possible capacity issues at receiving centers. Further studies are needed to evaluate the benefits and negative consequences of regionalizing revision TJA services to higher-volume revision TJA institutions. LEVEL OF EVIDENCE: Level III, therapeutic study.

Entities:  

Mesh:

Year:  2019        PMID: 30998640      PMCID: PMC6494322          DOI: 10.1097/CORR.0000000000000684

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  41 in total

1.  Potential benefits of the new Leapfrog standards: effect of process and outcomes measures.

Authors:  John D Birkmeyer; Justin B Dimick
Journal:  Surgery       Date:  2004-06       Impact factor: 3.982

2.  Future clinical and economic impact of revision total hip and knee arthroplasty.

Authors:  Steven M Kurtz; Kevin L Ong; Jordana Schmier; Fionna Mowat; Khaled Saleh; Eva Dybvik; Johan Kärrholm; Göran Garellick; Leif I Havelin; Ove Furnes; Henrik Malchau; Edmund Lau
Journal:  J Bone Joint Surg Am       Date:  2007-10       Impact factor: 5.284

3.  Influence of hospital volume on revision rate after total knee arthroplasty with cement.

Authors:  Mona Badawy; Birgitte Espehaug; Kari Indrekvam; Lars B Engesæter; Leif I Havelin; Ove Furnes
Journal:  J Bone Joint Surg Am       Date:  2013-09-18       Impact factor: 5.284

4.  Current Epidemiology of Revision Total Knee Arthroplasty in the United States.

Authors:  Ronald E Delanois; Jaydev B Mistry; Chukwuweike U Gwam; Nequesha S Mohamed; Ujval S Choksi; Michael A Mont
Journal:  J Arthroplasty       Date:  2017-04-06       Impact factor: 4.757

5.  Risk for Complication after Total Joint Arthroplasty at a Center of Excellence: The Impact of Patient Travel Distance.

Authors:  Benedict U Nwachukwu; Christopher J Dy; Jayme C Burket; Douglas E Padgett; Stephen Lyman
Journal:  J Arthroplasty       Date:  2015-01-19       Impact factor: 4.757

6.  Cost Analysis of Total Joint Arthroplasty Readmissions in a Bundled Payment Care Improvement Initiative.

Authors:  Andrew J Clair; Perry J Evangelista; Claudette M Lajam; James D Slover; Joseph A Bosco; Richard Iorio
Journal:  J Arthroplasty       Date:  2016-02-24       Impact factor: 4.757

7.  Revision total hip arthoplasty: factors associated with re-revision surgery.

Authors:  Monti Khatod; Guy Cafri; Maria C S Inacio; Alan L Schepps; Elizabeth W Paxton; Stefano A Bini
Journal:  J Bone Joint Surg Am       Date:  2015-03-04       Impact factor: 5.284

8.  Distance bias and surgical outcomes.

Authors:  David A Etzioni; Richard J Fowl; Nabil Wasif; John H Donohue; Robert R Cima
Journal:  Med Care       Date:  2013-03       Impact factor: 2.983

9.  Procedural volume as a marker of quality for CABG surgery.

Authors:  Eric D Peterson; Laura P Coombs; Elizabeth R DeLong; Constance K Haan; T Bruce Ferguson
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

10.  Relation between surgeon volume and risk of complications after total hip arthroplasty: propensity score matched cohort study.

Authors:  Bheeshma Ravi; Richard Jenkinson; Peter C Austin; Ruth Croxford; David Wasserstein; Benjamin Escott; J Michael Paterson; Hans Kreder; Gillian A Hawker
Journal:  BMJ       Date:  2014-05-23
View more
  15 in total

1.  Are high-risk patient and revision arthroplasty effective indications for closed-incisional negative-pressure wound therapy after total hip or knee arthroplasty? A systematic review and meta-analysis.

Authors:  Jun-Ho Kim; Dae-Hee Lee
Journal:  Int Wound J       Date:  2020-05-13       Impact factor: 3.315

2.  Can machine learning models predict failure of revision total hip arthroplasty?

Authors:  Christian Klemt; Wayne Brian Cohen-Levy; Matthew Gerald Robinson; Jillian C Burns; Kyle Alpaugh; Ingwon Yeo; Young-Min Kwon
Journal:  Arch Orthop Trauma Surg       Date:  2022-05-04       Impact factor: 3.067

3.  Preoperative diabetes complicates postsurgical recovery but does not amplify readmission risk following pancreatic surgery.

Authors:  Mohammad Hosny Hussein; Eman Ali Toraih; Adin Reisner; Areej Shihabi; Zaid Al-Quaryshi; Jeffrey Borchardt; Emad Kandil
Journal:  Gland Surg       Date:  2022-04

Review 4.  [Planning revision hip arthroplasty : What are the structural requirements?]

Authors:  Wolfram Mittelmeier; Katrin Osmanski-Zenk
Journal:  Orthopadie (Heidelb)       Date:  2022-06-23

5.  Patients Who Undergo Early Aseptic Revision TKA Within 90 Days of Surgery Have a High Risk of Re-revision and Infection at 2 Years: A Large-database Study.

Authors:  Tony S Shen; Alex Gu; Patawut Bovonratwet; Nathaniel T Ondeck; Peter K Sculco; Edwin P Su
Journal:  Clin Orthop Relat Res       Date:  2022-03-01       Impact factor: 4.755

6.  Local Trends in Total Joint Arthroplasty and Orthopaedic Surgeon Distribution in the United States.

Authors:  Christopher M Scanlon; Brian A Perez; Austin Yu; Matthew Sloan; Amanda Milena Alvarez; Matthew L Webb; Neil P Sheth
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-07-06

7.  Total Joint Arthroplasty at a Tertiary Military Medical Center in Hawai'i: Does Travel Distance Influence Short Term Complications?

Authors:  Gregory E Lausé; M Justin Willcox; Duke G Yim
Journal:  Hawaii J Health Soc Welf       Date:  2021-05

8.  Which Factors Predict 30-Day Readmission After Total Hip and Knee Replacement Surgery?

Authors:  Cynthia L Williams; George Pujalte; Zhuo Li; Rock P Vomer; Maruoka Nishi; Lisa Kieneker; Cedric J Ortiguera
Journal:  Cureus       Date:  2022-03-12

9.  Integrated care systems in trauma to elective care: Can we emulate the integration of services in orthopaedic trauma care within elective practice?

Authors:  Joshua W Thompson; Fares S Haddad
Journal:  Bone Jt Open       Date:  2021-06

10.  Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?

Authors:  Azeem Tariq Malik; John H Alexander; Safdar N Khan; Thomas J Scharschmidt
Journal:  Clin Orthop Relat Res       Date:  2020-03       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.